MASS
908 Devices Inc.
NASDAQ · USHealthcareMedical - Devices
$7.03-4.35%
Price as of Jul 20, 2026
MASS growth
908 Devices Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +2.2%
- EBITDA
- +8.4%
- EBIT
- +52.8%
- EPS
- -78.2%
- Free cash flow
- +76.5%
- Operating cash flow
- +78.9%
Forward estimates
- Revenue
- -37.9%
- EBITDA
- +21.8%
- EPS
- +93.7%
Three-year CAGR
- Revenue
- +6.2%
- EBITDA
- +34.2%
- EBIT
- +68.5%
- Net income
- +49.3%
- EPS
- +125.5%
- Free cash flow
- +20.1%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.